Susanne Munksted

Chief Growth Officer | Strategic Growth

As Chief Growth Officer, Susanne shapes the strategic direction of Diaceutics' next phase of expansion. Identifying new opportunities beyond our core business to build organic growth and overseeing the acquisitions, partnerships, and investment decisions that translate into long-term shareholder value. She also leads the company's external thought leadership agenda, using Diaceutics' Practice Gaps research to educate the market and influence how the industry approaches patient access. Susanne brings broad commercial experience in precision medicine and molecular pathology, having led multiple global launches of Diagnostic products, and has been recognised on the PharmaVoice 100 list of transformational leaders in life sciences.